New Same-Day test could transform cervical cancer screening in Low-Resource areas

NCT ID NCT07550010

Recruiting now Diagnosis Sponsor: University Hospital, Geneva Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study evaluates a same-day cervical cancer screening approach for women in Cameroon. Participants first collect their own sample for HPV testing, and if positive, they receive a digital cytology exam on the same day to determine if further treatment is needed. The goal is to see if this fast, all-in-one strategy can accurately detect precancerous changes and be practical in low-resource settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING METHODS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical intraepithelial neoplasia grade 2/3 human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER SCREENING METHODS CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2 (CIN2) HUMAN PAPILLOMAVIRUS INFECTION

Contacts and locations

Locations

Centre Hospitalier Universitaire de Yaoundé
RECRUITING

Yaoundé, Cameroon
Yaoundé University Teaching Hospital (CHU)
RECRUITING

Yaoundé, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.